We are live on !
Find out more
CQS Cayman Portfolio holdings
AUM
$2.26B
Turnover
34.41%
1-Year Est. Return
1.31%
This Fund
S&P 500
This Quarter Est. Return
-4.15%
1 Year Est. Return
+1.31%
3 Year Est. Return
+15.29%
5 Year Est. Return
+28.07%
10 Year Est. Return
–
AUM
$1000M
AUM Growth
-$449M
(-31%)
Cap. Flow
-$599M
Cap. Flow % of AUM
Cap. Flow %
-59.89%
Top 10 Holdings %
Top 10 Hldgs %
51.78%
Holding
160
New
20
Increased
18
Reduced
20
Closed
56
Avg Time Held
Equity + Options
0.8
years
Top 10 Avg Time Held
Equity + Options
0.4
years
Top 20 Avg Time Held
Equity + Options
0.4
years
Avg Time Held Equity only
0.8
years
Top 10 Avg Time Held Equity only
0.5
years
Top 20 Avg Time Held Equity only
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$37.7M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$36.4M |
| 3 |
Liberty Global Class A
LBTYA
|
+$13.8M |
| 4 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$10.3M |
| 5 |
Warner Bros
WBD
|
+$8.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ryanair
RYAAY
|
+$54.5M |
| 2 |
TSNU
Tyson Foods, Inc.
TSNU
|
+$27.3M |
| 3 |
BKHU
Black Hills Corporation
BKHU
|
+$22.2M |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$11.6M |
| 5 |
Liberty Media Corporation Series C Common Stock
FWONK
|
+$9.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 57.5% |
| 2 | Healthcare | 13.66% |
| 3 | Consumer Discretionary | 9.91% |
| 4 | Communication Services | 6.3% |
| 5 | Technology | 3.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Carnival Corporation Ltd
CCL
$35.1B
| $83.9M | 8.4% |
1,595,289
+751,372
| +89% | +$36.4M |
2015 Q1
4 quarters
|
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $58.3M | 5.83% |
217,347
+131,619
| +154% | +$37.7M |
2015 Q4
1 quarter
|
|
|
3
Ryanair
RYAAY
$27.2B
| $23.3M | 2.33% |
676,785
-1,653,163
| -71% | -$54.5M |
2015 Q2
3 quarters
|
|
|
4
Liberty Global Class A
LBTYA
$2.68B
| $14.8M | 1.48% |
+439,332
| New | +$13.8M |
2016 Q1
0 quarters
|
|
5
Zoetis
ZTS
$33.5B
| $12.4M | 1.24% |
280,395
+142,891
| +104% | +$6.06M |
2015 Q1
4 quarters
|
|
6
Liberty Latin America Class A
LILA
$1.58B
| $11.5M | 1.15% |
511,384
+108,173
| +27% | +$2.41M |
2015 Q4
1 quarter
|
|
|
7
Teva Pharmaceutical Industries Limited
TEVA
$46B
| $11.4M | 1.14% |
212,436
+175,558
| +476% | +$10.3M |
2015 Q4
1 quarter
|
|
|
NSM
8
DELISTED
Nationstar Mortgage Holdings
NSM
| $9.7M | 0.97% |
975,549
+75,549
| +8% | +$805K |
2015 Q2
3 quarters
|
|
|
AET
9
DELISTED
Aetna Inc
AET
| $9.33M | 0.93% |
83,012
-16,200
| -16% | -$1.73M |
2015 Q4
1 quarter
|
|
|
RHT
10
DELISTED
Red Hat Inc
RHT
| $9.25M | 0.93% |
124,126
+11,839
| +11% | +$835K |
2014 Q4
5 quarters
|
|
11
Altisource Portfolio Solutions
ASPS
$64.6M
| $9.1M | 0.91% |
47,128
-11,785
| -20% | -$2.51M |
2015 Q2
3 quarters
|
|
|
12
DELISTED
Warner Bros
WBD
| $8.86M | 0.89% |
+309,480
| New | +$8.28M |
2016 Q1
0 quarters
|
|
|
13
Liberty Media Corporation Series C Common Stock
FWONK
$22.4B
| $8.36M | 0.84% |
310,288
-375,050
| -55% | -$9.32M |
2015 Q3
2 quarters
|
|
14
PUT
Franklin Templeton
BEN
$15.8B
| $7.81M | 0.78% |
200,000
| – | – |
2015 Q4
1 quarter
|
|
15
Atlassian
TEAM
$57.6B
| $7.65M | 0.77% |
304,285
+42,485
| +16% | +$995K |
2015 Q4
1 quarter
|
|
16
News Corp Class A
NWSA
$16.6B
| $7.55M | 0.75% |
590,935
+189,054
| +47% | +$2.24M |
2015 Q4
1 quarter
|
|
|
LVNTA
17
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $7.48M | 0.75% |
191,195
+23,731
| +14% | +$901K |
2015 Q2
3 quarters
|
|
18
McKesson
MCK
$117B
| $7.14M | 0.71% |
+45,416
| New | +$7.34M |
2016 Q1
0 quarters
|
|
19
Incyte
INCY
$23.5B
| $6.98M | 0.7% |
+96,250
| New | +$7.17M |
2016 Q1
0 quarters
|
|
|
GRA
20
DELISTED
W.R. Grace & Co.
GRA
| $6.92M | 0.69% |
97,265
-32,340
| -25% | -$2.47M |
2015 Q4
1 quarter
|
|
|
MON
21
DELISTED
Monsanto Co
MON
| $6.47M | 0.65% |
73,749
+31,294
| +74% | +$2.82M |
2015 Q3
2 quarters
|
|
22
Zimmer Biomet
ZBH
$18.8B
| $6.46M | 0.65% |
+62,425
| New | +$6.04M |
2016 Q1
0 quarters
|
|
23
Biogen
BIIB
$37B
| $6.4M | 0.64% |
24,600
-28,745
| -54% | -$7.59M |
2015 Q3
2 quarters
|
|
24
Constellium
CSTM
$3.15B
| $5.76M | 0.58% |
+1,110,000
| New | +$6.38M |
2016 Q1
0 quarters
|
|
25
DELISTED
EMC CORPORATION
EMC
| $5.51M | 0.55% |
206,700
+70,200
| +51% | +$1.78M |
2015 Q4
1 quarter
|
|
Similar funds
RCM
GVI
TAM
AWM
CQS Cayman's Q1 2016 Portfolio in Review
As of Q1 2016, CQS Cayman held 160 positions worth $1000M, down 31% from $1.45B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
CQS Cayman withdrew a net $599M in Q1 2016, closing 56 positions and reducing 20 holdings. Its most notable exit was Tyson Foods, Inc., an estimated $27.3M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, down from 68% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, CQS Cayman opened a new position in Liberty Global Class A worth $14.8M.
- CQS Cayman's largest Q1 2016 buy was Liberty Global Class A: 439,332 shares worth $14.8M.
- CQS Cayman added most to Allergan plc in Q1 2016, an estimated $37.7M increase.
- CQS Cayman's biggest Q1 2016 reduction was Ryanair, cutting an estimated $54.5M.
- CQS Cayman fully exited Tyson Foods, Inc. in Q1 2016, selling an estimated $27.3M.
- CQS Cayman's ten largest holdings make up 52% of its $1000M portfolio in Q1 2016.
- CQS Cayman opened 20 new positions and closed 56 in Q1 2016.
- CQS Cayman's portfolio value fell 31% quarter-over-quarter to $1000M.
Based on CQS Cayman's 13F filing for Q1 2016, filed 4 May 2016.